Tokyo, Feb. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060688) titled 'A Study on the Usefulness of Saliva-Based Cancer Risk Testing (SalivaChecker)' on Feb. 16.
Study Type:
Observational
Primary Sponsor:
Institute - Aichi Gakuin University
Condition:
Condition - participants undergoing comprehensive medical checkups
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We will perform the SalivaChecker test on individuals undergoing comprehensive medical checkups and calculate the negative risk rate (specificity) among those who show no abnormalities in the checkup. Based on these findings, we will comprehensively evaluate the usefulness of saliva-based cancer risk assessment using the SalivaChecker test.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - participants undergoing comprehensive medical checkups
Key exclusion criteria - Individuals who did not provide consent.
Individuals with severe oral dryness that makes saliva collection difficult.
Target Size - 60
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 12 Month 01 Day
Date of IRB - 2025 Year 12 Month 07 Day
Anticipated trial start date - 2026 Year 02 Month 01 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069407
Disclaimer: Curated by HT Syndication.
